I. INTRODUCTION
Measurement of physiological pressures is often used for diagnosis and evaluation of therapeutic interventions. These range from the non-invasive blood pressure measurement during an office visit to indwelling pressure sensors used in intensive care units [1] , [2] . In certain situations, such as measurement of the intracranial pressure (ICP), where one needs access to a cranial space, the measurement require a high level of technical competence and must be performed in a sterile clinical setting [3] . In such cases, it is advantageous to use implantable sensors, in particular if pressure needs to be monitored for a long period of time [4] . Efforts in the area of implantable pressure sensors have been hampered by the sensor drift, in particular base-line drift, which degrades the measurement accuracy over time. This is in particular serious if re-calibration cannot be easily performed (e.g., intracranial pressure). The major sources of drift in implantable pressure sensors are related to the environmental factors, in particular absorption of moisture and bodily fluids by the material used in the sensor's packaging.
Polymeric materials used for device packaging and protection are in particular hygroscopic and can absorb a significant amount of moisture, resulting in package stress which can be transmitted to the sensing element, Figure 1 . Most efforts to reduce the base-line drift have been focused on packaging and material know how. One solution adopted by Data Sciences International (https://www.datasci.com/) in their implantable systems is to place the sensor inside a hard-shell package along with other electronic components and connect it to the source of pressure via a gel-filled catheter (reported base-line drift of 2-3 mmHg after several months of implantation [5] , [6] ). Other groups have reported on low-drift sensors utilizing custom-made packages that are carefully designed and fabricated to avoid the use of any polymeric materials in the device and packaging [7] , [8] . For example, Kroin et al. have reported on a titanium capacitive pressure sensor for intracranial applications having an average of 0.3 mmHg drift after 3-6 months of implantation [8] . Another notable example is the MEMS-based implantable pressure sensors commercialized by CardioMEMS (http://www.sjm.com/cardiomems) in which a complete-glass structure removes many sources of drift associated with disparate polymeric materials used in the package (although no data on long-term drift is made public, the device has been successfully implanted in human subject for many months [9] , indicating a low-drift operation).
As discussed above, designs and manufacturing methods reported for low-drift implantable pressure sensors often require complicated steps and in-house expertise, which can hamper wider adoption of the techniques by the clinical and research communities. In this paper, we present a low cost and universal/generic solution to reduce the baseline drift by isolating the sensor in a silicone-filled balloon. The concept is validated by monitoring the baseline drift in an in-vitro aqueous environment and an in-vivo porcine model (Ossabow pig).
II. FLUID-ISOLATED PACKAGE DESIGN AND ITS FABRICATION PROCESS
The universal fluidic-isolation packaging technique reported here employs a modular design approach and is adaptable to many implantable systems. Such modular design physically separates the sensor and the rest of the system (readout and wireless transmission circuitry) while allowing the sensor to maintain a small form factor and be placed near the source of pressure (i.e., target organ). Figure 2 depicts a schematic of the packaging technique in which the sensor is isolated from the aqueous environment by complete encapsulation in a medical-grade thin polyurethane balloon filled with a biocompatible incompressible fluid. The packaging requires an inert non-aqueous fluid such as silicone oil to avoid any interaction with the sensing element and associated polymeric materials (e.g., Parylene-C or epoxy glue used in packaging) used in the assembly of the sensor. It is important that the balloon enclosing the fluid and the sensing element to be chemically resistant to the biological environment, strong, and impermeable to both isolation and body fluids. A thin wall medical-grade polyurethane balloon fulfills these requirements.
The sensor packaging procedure is illustrated in Figure 3 . Described packaging technique can be applied to any conventional diaphragm-based pressure sensor. In the prototype development, a commercial piezoresistive pressure sensor was used (Measurement specialties, MS5637-02BA03), Figure 3 (a). The sensor is intended for barometric pressure measurement (dynamic range of 225-900 mmHg (306-1224 cmH2O) and resolution of 0.08 mmHg (0.1 cmH2O)); however, it can be adapted for biomedical purposes with proper packaging. This particular sensor has also an on-board temperature sensor and its internal microcontroller automatically compensates for temperature variations. This removes the need for using a temperaturecontrolled oven that is typically used for in-vitro validation experiments. The sensor has a small form factor (3×3×0.9 mm 3 ), enabling for wide adoption in medical applications.
The packaging starts with bonding the pressure sensor to a custom-made (EPEC LLC) polyimide flexible cable containing electrical interconnects for interfacing with the electronic circuitry (the polyimide flexible cable is designed to have a certain length at both the distal and proximal ends to provide for a full encapsulation by the medical-grade balloon). After mounting and securing the sensor to the polyimide cable, a thin layer of parylene-C (5 m) is deposited on the assembly for passivation, Figure 3 (b). Note that the fabrication was done under clean-room condition up to this point. Subsequently, the sensor is encased in a thin (31-44 m), medicalgrade, polyurethane balloon (Vention Medical, 06001000CA) [10] , Figure 3 (c). The balloon used in our prototype is 10 mm in length, 6 mm in diameter in the middle section, and 2.5 mm in diameter in the proximal/distal ends. Following the placement of the sensor inside the balloon, the proximal junction of the balloon with the flexible cable is sealed using a UV-curable acrylated urethane adhesive (Loctite, 3106 cured under a UV lamp, 100 mW/cm 2 for 5 minutes).
The adhesive offers a leak-proof seal over the polyurethane [11] . After closing the proximal end, 
III. EXPERIMENTAL RESULTS

A. In-Vitro Characterizations
The prototypes were evaluated in-vitro by comparing them with: 1) a commercial reference pressure sensor (called reference from here on) and 2) another sensor without the fluid-isolation packaging (i.e., parylene C coated sensor in direct contact to saline, Figure 3 This indicates an on-going process, which is mostly due to the absorption of water into the packaging materials and resulting slow degradation of certain materials under the ionic aqueous conditions. We believe that the source of the initial aging effect is partly due to the continuous operation of the sensor in the power-up mode which can result in certain aging process in the components, settling down after 30 days (< ±2 cmH2O). This is a common phenomenon reported by other investigators [7, 8] 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 These results clearly demonstrate that the described fluidic-isolation packaging method is capable of protecting the sensors against saline solution (i.e., aqueous environment) for an extended period. The table 1 compares the described packaging method with other reported lowdrift implantable pressure sensors. As can be seen, our simple and generic packaging technique yields baseline drifts that are very similar to some of the lowest ones reported in the literature, all of which rely on more sophisticated material selection and manufacturing methods.
B. In-Vivo Tests
We also implanted our pressure sensor in the bladder wall of Ossabow miniature pig. The study was approved by the Institutional Animal Care and Use Committee at Indiana University School of Medicine. Pre-and post-implant calibrations were performed using a clinical urodynamic studies equipment (Laborie Delphis machine, Laborie, Toronto, Canada), Figure   4 (c). The urodynamic system measures the maximum and minimum pressures that a bladder can hold using a catheter-tip-mounted pressure transducer (PBS solution is pumped into the bladder during the measurements). The calibrations were done to measure the bladder pressure when filled with 0 to 1500 cc of PBS (filling and voiding). In order to reduce the effects of initial aging processes, the pressure sensors were pre-soaked in PBS for 30 days prior to the implantation.
The packaged sensors were implanted beneath the bladder mucosa [12] and were connected to a sub-cutaneous module housing the interface electronics and RF transmitter via the polyimide flex cable [13] . Figure 8 shows a photograph of the packaged sensor taken during the implantation.
In order to reduce the animal distress and bladder infection during the experiments, the approved protocol did not allow bladder catheterization and cross-correlation measurements with the urodynamic system on a daily basis. Therefore, the only cross-referencing measurements were the ones performed under anesthesia at the beginning and termination of the experiments (when the device was implanted and explanted). In spite of this limitation, one can still make reasonable deductions regarding the cumulative sensor drift for the duration of the implant by measuring and characterizing the sensor immediately following ex-plantation. calibrations and subsequent transfer of the animal to a care facility, the bladder pressures were wirelessly monitored for a period of 12 days [13] . Figure 10 shows the pressure measurements during the investigation period. In both plots, the very first peak indicates the calibrations (equivalent to Figure 9 (a) and (b)). All bladder pressures measured during the experiment period fell within the minimum and maximum pressure range that the bladder can handle, in other words, there were no outlier. The insets in Figure 10 show close-ups of daily urinary activities,
clearly indicating the bladder function during the day and night; the bladder typically has a higher pressure (> 10 cmH2O) during the daytime and a lower pressure (< 10 cmH2O) during the nighttime.
The packaged sensors were explanted after the investigation period. Before removing the devices, the sensors were re-calibrated against the urodynamic system to investigate the baseline drift during the in-vivo experiment. The two-point calibration showed that the sensor performance remained virtually identical after 12 days showing less than 1% variations in both sensitivity and baseline. Although due to the abovementioned protocol limitation and technical difficulties, we could not collect in-vivo data for a longer stretch of time, we feel confident that encapsulating the sensor in an inert non-aqueous medium can significantly reduce the drift.
IV. CONCLUSION
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